A higher serotonin synthesis and accumulation in male zebrafish resulted in increased activation of hepatic stellate cells and transforming growth factor B1 expression and this has contributed to the accelerated progression of hepatocellular carcinoma in male zebrafish with activated kras oncogene expression.
See editorial on page 301. H epatocellular carcinoma (HCC) is notably more prevalent in men than in women, with a maleto-female ratio of 4.5:1. 1 The sex disparity appears to be mediated by a sex hormone-regulated mechanism. After menopause, women showed increased occurrence of HCC, which could be reduced with estrogen treatment. 2, 3 In a carcinogen-induced mouse HCC model, administration of estrogen to male mice inhibited HCC development. 4 It is interesting to note that effects elicited by sex hormones are associated commonly with tumor microenvironmentmediated inflammatory response. For example, estrogen inhibits interleukin 6 expression in Kupffer cells (liver resident macrophages) and confers resistance to HCC in female mice. 5 Androgen signaling polarizes tumorassociated macrophages to a protumor gene expression profile during early hepatocarcinogenesis. 6 Interestingly, numerous HCC studies have shown a more robust and active HCC tumor microenvironment in males than in females. For example, infiltrating tumor-associated macrophage density has been found to be higher in males than in females in a mouse HCC model. 7 In human HCC patients, men have considerably higher numbers of intratumoral infiltrated CD66bþ neutrophils and CD8þ T cells; both are indicators of poor disease prognosis. 8 Hepatic stellate cells (HSCs), the main fibrinogenic cell type in the liver, primarily are responsible for the production of extracellular matrix materials. [9] [10] [11] Recent studies have shown a tumor-promoting role of HSCs. 12 Tumor cell-secreted signals promote HSCs to transdifferentiate into highly proliferating myofibroblast-like cells, also known as activated HSCs. 13 Activated HSCs can induce phenotypic changes in cancer cells, primarily by secretion of protumor growth factors and cytokines such as hepatocyte growth factor and transforming growth factor (TGF)b1. 14 An increased HSCspecific gene expression signature in HCC patients indicates poor prognosis. 15 Notably, HSCs are found to be of higher density in male than in female HCC patients. 16 Because only activated HSCs rapidly proliferate, a higher HSC density in male HCC patients implies that a sex-dependent mechanism could contribute to activation of HSCs. 13 Our laboratory previously generated several inducible HCC models by transgenic expression of an oncogene in hepatocytes in zebrafish. [17] [18] [19] [20] [21] The inducible nature of these zebrafish HCC models allows the oncogene to be activated at a given and controlled timing in both sexes, providing an excellent platform to study sex disparity in HCC initiation and progression. In this study, we attempted to investigate the mechanism of the sex disparity observed in HCC patients. In our kras V12 -expressing HCC zebrafish model, male fish showed accelerated carcinogenesis as compared with females. 17 Interestingly, we found an increased level of serotonin production in male kras V12 -expressing livers as compared with female counterparts and showed that serotonin was necessary for maintaining HSC survival and activation during HCC carcinogenesis. The activated HSCs in turn promoted HCC progression and at the same time increased serotonin synthesis in hepatocytes via Tgfb1, hence maintaining and promoting the sex disparity observed in kras V12 -expressing zebrafish. The findings in zebrafish were confirmed by our analyses of human liver disease patient samples, suggesting that serotonin is involved in the sex disparity of human HCC.
Materials and Methods

Zebrafish Husbandry
Zebrafish were maintained in compliance with Institutional Animal Care and Use Committee guidelines from the National University of Singapore. Five transgenic lines, Tg(fabp10:rtTA2s-M2; TRE2:EGFP-kras G12V ) (gz32Tg) in a tetracycline-controlled transcription activation (Tet-On) system for inducible hepatocyte-specific expression of oncogenic kras G12V , 17 Tg(hand2:EGFP) (pd24Tg) with EGFPlabeled HSCs under the hand2 promoter, 22 Tg(tp1:EGFP) (um14Tg) with EGFP-labeled cholangiocytes under a notchresponsive element, 23 Tg(lyz:DsRed2) (nz50Tg) with DsRedlabeled neutrophils under the lysozyme C (lyz) promoter, 24 Tg(mpeg1:mCherry) (gl22Tg), with mCherry-labeled macrophages under the mpeg1 promoter, 25 and Tg(fabp10:DsRed; ela3l:EGFP) (gz15Tg) with DsRed-labeled hepatocytes under the fabp10 promoter 26 were used in this study and referred to as krasþ, hand2þ, lyzþ, mpegþ, and fabp10þ, respectively, in the present report.
Chemical Treatment
All chemical/reagent treatments were conducted in 3-month-old adult fish for 7 days. The chemicals/reagents used included doxycycline (dox) (D9891; Sigma-Aldrich, St. Louis, MO), serotonin (14927; Sigma), PCPA (4-chloro-DLphenylalanine) (C6506; Sigma), BW723C86 (B175; Sigma), SB204741 (S0693; Sigma), and SB431542 (1614; Tocris, Minneapolis, MN). Serotonin, PCPA, BW723C86, SB204741, SB431542, and dox were used for adult exposure at 10 mmol/ L, 25 mmol/L, 15 mmol/L, 15 mmol/L, 2.5 mmol/L, and 30 mg/ mL, respectively. The dosages were selected based on the highest all-survival concentrations in preliminary experiments.
Photography and Image Analysis
At each time point of chemical treatment experiments, more than 10 adult fish in each group were used for imaging analyses. These zebrafish were anesthetized in 0.08% tricaine (E10521; Sigma) and immobilized in 3% methylcellulose (M0521; Sigma) before imaging. Each zebrafish was photographed individually with an Olympus microscope (Olympus, Tokyo, Japan).
Isolation of Hepatocytes, Neutrophils, Macrophages, Cholangiocytes, and HSCs by Fluorescence-Activated Cell Sorting Fabp10þ, lyzþ, mpegþ, tp1þ, and hand2þ transgenic zebrafish in wild-type background were used for fluorescence-activated cell sorting isolation of hepatocytes, neutrophils, macrophages, cholangiocytes, and HSCs, respectively, using a cell sorter (643245; BD Biosciences, Singapore). Ten adult livers were pooled and dissociated into single cells in the presence of 0.05% trypsin (T1426; Sigma) using a 40-mm mesh (352340; Fisher Scientific, Pittsburgh, PA) as previously described. 27 Hepatocytes (fabp10þ), cholangiocytes (tp1þ), and HSCs (hand2þ) were isolated based on EGFP expression, neutrophils (lyzþ) were isolated based on DsRed expression, and macrophages (mpegþ) were isolated based on mCherry expression. 
RNA
Histologic and Cytologic Analyses
Ten adult livers were fixed in 4% paraformaldehyde in phosphate-buffered saline (P6748; Sigma), embedded in paraffin, and sectioned at 5-mm thickness using a microtome, followed by H&E, PicroSirus Red, Gomori's trichome, immunohistochemistry (IHC), or immunofluorescence (IF) stainings. H&E (H-3404; Vector Laboratories, Burlingame, CA, USA), Picrosirius Red (24901B; Polyscience, Inc, Warrington, PA), and Gomori's trichome (87021; Thermo Fisher Scientific, Singapore) stainings were conducted according to the manufacturers' protocols. For IHC and IF stainings, the primary antibodies were derived mostly from rabbits, including anti-proliferating cell nuclear antigen (PCNA) (FL-261; Santa Cruz Biotechnology, Dallas, TX), anti-caspase 3 (C92-065; BD Biosciences, Singapore), antiserotonin (C5545; Sigma), anti-TgfB1 (04-953; EMD Millipore, Billerica, MA), anti-PTph (SC135716; Santa Cruz), anti--a-smooth muscle actin (a-Sma) (ab15734; Abcam, Singapore), anti-PSmad2 (3101; Cell Signaling Technology, Danvers, MA) and anti-collagen I (ab23730; Abcam), except for anti-glial fibrillary acidic protein (Gfap) (154474; Abcam) from the mouse. Anti-rabbit or anti-mouse secondary antibodies were purchased from Thermo Fisher Scientific. At least 8 fish from each treatment group were examined and 1 high-power field was selected randomly from each fish liver and IF signals were counted manually for quantitative analyses.
Human Patient Samples
Paraffin-embedded human liver disease progression tissue microarray slides were purchased from Biomax, Inc (Derwood, MD) (LV8011a). Patients were classified into 4 groups: normal (n ¼ 5), inflammation (n ¼ 7), cirrhosis (n ¼ 16), and HCC (n ¼ 30). Histopathology of all patients was diagnosed by a pathologist based on the information provided from Biomax, Inc (https://www.biomax.us/tissuearrays/Liver/LV8011a). Patient samples slides were subjected to H&E staining and IHC staining for serotonin and TGFb1, respectively.
Statistical Analysis
Statistical significance between the 2 groups was evaluated by a 2-tailed unpaired Student t test using inStat version 5.0 for Windows (GraphPad, San Diego, CA). Statistical data are presented as means ± SDs.
Results
More Aggressive HCC Progression in Male Kras V12 -Expressing Livers
In human patients, men develop more aggressive HCC with larger tumors and a lower survival rate than women. [28] [29] [30] To examine if our kras V12 -expressing HCC zebrafish model recapitulated the sex disparity, male and female adult krasþ zebrafish were exposed to dox for 7 days. Initial gross morphologic examination of these krasþ zebrafish showed significantly enlarged livers in krasþ males than in krasþ females after 7 days of dox induction ( Figure 1A ). Histologically, kras V12 -expressing livers in males showed more advanced HCC phenotype than that in females. In males, kras V12 -expressing hepatocytes were densely situated with lost organization of the typical 2-cell hepatic plates; these are typical features of carcinoma. In contrast, female kras V12 -expressing livers were either hyperplastic or adenoma; these livers largely maintained the 2-cell plate but had a more prominent nucleoli and vacuolated cytoplasm ( Figure 1A ). As summarized in Figure 1A , 60% of female kras V12 -expressing livers showed adenoma histology and the remaining 40% had hepatic hyperplasia; in contrast, 100% of the male kras V12 -expressing livers showed carcinoma or adenoma histology.
To further investigate the mechanism behind this sex disparity, the cell proliferation, apoptosis, and extent of hepatic fibrosis were examined. As expected, kras V12 -expressing hepatocytes had higher rates of cell proliferation and apoptosis than their wild-type (WT) siblings ( Figure 1B and C). When comparing the sexes, male kras V12 -expressing hepatocytes had a significantly higher numbers of proliferating but not apoptotic cells than female kras V12 -expressing hepatocytes. The extent of liver fibrosis could be a marker for early HCC. 31 By IF staining, male kras V12 -expressing livers showed a significantly higher expression of collagen I than WT siblings and also female kras V12 -expressing livers, reflecting its more advanced liver disease status ( Figure 1D ). Picrosirius Red and Gomori's trichrome staining, both of which stained for fibrotic tissues, showed consistent results with collagen I staining ( Figure 1E and F). -induced HCC progression. Three-month-old adult zebrafish were treated with 30 mg/mL dox for 7 days and examined by various assays as described in the text. (A) Gross morphology and histology of krasþ and WT (control) male and female zebrafish after dox exposure. Male kras V12 -expressing liver (green for green fluorescent protein expression) were enlarged significantly as compared with female kras V12 -expressing liver and also with WT male and female livers (dotted line enclosed). Bottom left: H&E staining of the liver sections of dox-treated krasþ and WT (control) male and female zebrafish. In human HCC, male HCC patients have a higher HSC density than female patients and a high HSC density signals a poor prognosis. 15, 16 Hence, HSC density and activation were investigated in our krasþ HCC zebrafish model. Gfapþ cells in the liver demarcate both activated and quiescent HSCs. 32 IF staining of Gfap on HSC reporter transgenic zebrafish, hand2þ, showed nearly 90% hand2þ cells were positive for Gfap staining in the liver; similarly, 89% of Gfapþ cells were hand2þ cells (Figure 2A-C) . Thus, there was high overlap between the 2 molecular markers for HSCs. 22 a-Sma is a marker for activated HSC 33 ; hence, Gfapþ/a-Smaþ cells in the liver were used to indicate activated HSCs ( Figure 2D ). With kras V12 expression, both total HSC density and the percentage of activated HSCs were significantly higher in male kras V12 -expressing livers than female ( Figure 2E ), indicating sex disparity in HSC activation in kras V12 -expressing livers. Serotonin has been shown to play an activating role on HSCs via 5-hydoxytryptamine receptor 2B (Htr2b) in a mouse liver regeneration model. 34 To investigate if htr2b played a role in sex disparity in the krasþ HCC model in zebrafish, reverse-transcription quantitative PCR was performed in fluorescence-activated cell sorting-isolated hepatocytes, neutrophils, macrophages, HSCs and cholangiocytes. Htr2b was found to be expressed the most strongly in both male and female HSCs, with marginal expression in neutrophils and macrophages, but almost no expression was found in hepatocytes and cholangiocytes of both sexes ( Figure 3A) . Overall, the levels of htr2b expression was higher in males than in females in all cell types examined.
To account for the increased HSC density and activation, serotonin level was examined in male and female kras V12 -expressing livers. Interestingly, IF staining of serotonin indicated a more significantly increase in kras V12 -expressing hepatocytes in males than in females ( Figure 3B and C) . To investigate the sex difference in serotonin level, expression of tryptophan hydroxylase 1b (Tph1b), the rate-limiting enzyme for serotonin biosynthesis, was examined. Male kras V12 -expressing hepatocytes showed an 8-fold increase in tph1b messenger RNA expression ( Figure 3D ). Tph1 can undergo phosphorylation to enhance protein stability. 35 IF staining of phosphorylated Tph1 (P-Tph1) in liver sections showed a higher expression of the phosphorylated enzyme in male kras V12 -expressing hepatocytes than female kras V12 -expressing hepatocytes ( Figure 3B and E) , suggesting that the sex disparity in serotonin levels was owing to the higher expression and phosphorylation of Tph1b in males than in females.
Serotonin Promotes
Gross morphology of both serotonin-and BW723C86-treated krasþ females showed significantly enlarged livers as compared with WT control females. In contrast, krasþ male zebrafish showed a significant deterrence of liver enlargement with exposure to PCPA or SB204741 ( Figure 4A and B) . Histologically, exposure to serotonin or activation of the Htr2b receptor significantly accelerated the rate of carcinogenesis because an increased portion of female kras V12 -expressing livers showed a loss of 2-cell hepatic plates. However, decreased percentages of fish with HCC histology were observed in male kras V12 -expressing livers after exposure to PCPA or SB204741 ( Figure 4C ). As summarized in Figure 4C , 75% and 38% of female kras V12 -expressing livers showed HCC histology when exposed to serotonin and BW723C86, respectively. In contrast, 25% and 20% of male kras V12 -expressing livers showed milder histology when exposed to PCPA and SB204741, respectively.
Cytologic analysis of cell proliferation was consistent with morphologic and histologic changes. After 7 days of dox exposure, male kras V12 -expressing livers had a significantly higher level of proliferating cells than females. Exposure of serotonin or BW723C86 to krasþ females significantly increased the level of proliferating cells. Conversely, exposure of SB204741 and PCPA significantly reduced the number of proliferating cells ( Figure 4D ). In contrast, exposure to PCPA or SB204741 to krasþ males increased apoptotic liver cells significantly ( Figure 4E ). IF staining of collagen I, Picrosirius Red, or Gomori's trichrome staining consistently indicated an increased collagen deposition in the extracellular matrix when comparing male and female kras V12 -expressing livers ( Figure 5 ). Exposure of Figure 3 . (See previous page). Htr2b expression and serotonin production after kras V12 induction. (A) Expression of htr2b in hepatocytes, HSCs, neutrophils, macrophages, and cholangiocytes. These cells were isolated by fluorescence-activated cell sorting based on DsRed, GFP, DsRed, mCherry, and GFP expression, respectively from fabp10þ, hand2þ, lyzþ, mpegþ, and tp1þ transgenic zebrafish. Total RNA was extracted and htr2b expression was determined by reversetranscription quantitative PCR. Relative expression levels are shown with the value from female hepatocytes set as 1. (B) IF co-staining of Hnf4a/Serotonin (top) and Hnf4a/P-Tph1 in liver sections. Three-month-old krasþ and WT, male and female zebrafish were treated with 30 mg/mL dox for 7 days. Serotonin and P-Tph level were examined. (C) Quantification of serotonin-positive hepatocytes in these zebrafish (n > 8 in each group). (D) Reverse-transcription quantitative PCR determination of tph1b expression in hepatocytes isolated by fluorescence-activated cell sorting from dox-treated krasþ and fabp10þ (kras-control) male and female fish. Fold change is shown between males and females in WT and krasþ fish. (E) Quantification of percentage of P-Tph1-positive hepatocytes in these zebrafish (n > 8 in each group). *P < .05. Scale bar: 20 mm. DAPI, 4
0 ,6-diamidino-2-phenylindole. krasþ female fish to BW723C86 increased collagen deposition as compared with krasþ female controls. In contrast, exposure to either SB204741 or PCPA decreased collagen deposition as compared with male krasþ control ( Figure 5 ). Hence, either serotonin or the activation of the Htr2b receptor could accelerate carcinogenesis significantly in our kras V12 -expressing model.
Serotonin-Activated HSCs Promote Carcinogenesis and Serotonin Synthesis via Tgfb1
It has been reported previously that serotonin is capable of activating HSCs via the Htr2b receptor. 34 To investigate if serotonin was responsible for the sex disparity in HSC density through controlling the Htr2b downstream signaling, IF co- staining of Gfap and a-Sma was performed on both female and male kras V12 -expressing livers. As shown in Figure 6A , activation of Htr2b signaling by BW723C86 but not serotonin significantly increased both the total HSC density and percentage of activated HSCs whereas inhibition of serotonin synthesis by PCPA or inhibition of Htr2b signaling by SB204741 decreased both the density and percentage of activated HSCs, as compared with female or male kras V12 -expressing livers, respectively ( Figure 6A ). Thus, serotonin regulates HSCs through Htr2b, which could increase both the proliferation and activation of HSCs.
It has been reported that Htr2b activation is required for both HSC survival and tgfb1a expression. 34 To further elucidate the molecular outcome of Htr2b activation, expression of tgfb1a was examined in various cell types in the liver, including hepatocytes, HSCs, neutrophils, macrophages, and cholangiocytes. As shown in Figure 6B , HSCs had the highest level of tgfb1a expression in both male and female adult zebrafish ( Figure 6B ). Treatments with serotonin or BW723C86 significantly increased the percentage of Tgfb1-expressing HSCs in female kras V12 -expressing livers whereas treatments with PCPA or SB204741 significantly decreased HSCs of male kras V12 -expressing livers ( Figure 6C ). IF co-staining of Gfap with caspase-3 or Tgfb1 also was performed to show apoptotic HSCs (Gfapþ/Cas3þ). In contrast, the percentage of apoptotic HSCs remained unchanged in female kras V12 -expressing livers exposed to serotonin or BW723C86, but there was a significant increase in apoptotic HSCs in male kras V12 -expressing livers exposed to PCPA or SB204741 ( Figure 6D ). In contrast, therefore, serotonin activation of Htr2b signaling in HSCs is necessary for HSC survival as well as increased Tgfb1 expression.
Curiously, IF staining of serotonin indicated that BW723C8 activation of Htr2b in female kras V12 -expressing hepatocytes increased serotonin significantly, suggesting increased Tgfb1 or HSCs activation could promote serotonin synthesis ( Figure 7A ). To confirm the role of HSCs or Tgfb1 in serotonin synthesis, 3-month-old adult krasþ male zebrafish were exposed to either SB204741 or SB431542 (Tgfb receptor 2 inhibitor) for 7 days. Inhibition of HSCs or Tgfb signaling relaxed the HCC histology in male kras V12 -expressing livers ( Figure 7B ). Cytologic analysis of proliferating cells showed a significant decrease with both SB204741 and SB431541 exposure ( Figure 7C ). Tgfb1 is known to induce both cell senescence and apoptosis. 36, 37 b-galactosidase staining for senescent cells showed no difference between 3-month-old adult krasþ female and krasþ male zebrafish after exposure to SB204741 or SB431542 (data not shown), whereas IF staining of caspase-3 showed significantly higher apoptotic cells with either SB204741 or SB431542 exposure to krasþ males ( Figure 7D) . Notably, both SB204741-and SB431542-treated zebrafish showed decreased Tgfb1 expression and corresponding down-regulation of phosphorylated Erk (P-Erk) and phosphorylated Smad2 (PSmad2) signaling ( Figure 7E and F) , suggesting that inhibition of Htr2b-mediated HSC activation or inhibition of Tgfbr2 decreased both Tgfb1 expression and its downstream signaling. Interestingly, inhibition of both HSC activation and Tgfb1 signaling showed an inhibition of Tph1 phosphorylation and hence the serotonin production ( Figure 7G and H) , suggesting a potential role of HSC and their secreted Tgfb1 in regulating Tph1 activity.
Sex Differences in Serotonin and TGFB1 Level in Human Liver Disease Patients
In human liver diseases, serum serotonin levels have been shown to increase significantly in patients with cirrhosis and HCC. 38 To observe if the sex disparate serotonin levels observed in our kras V12 HCC zebrafish model would be reflected in human patients, a panel of liver disease samples, including normal, liver inflammation, cirrhosis, and HCC, were analyzed for levels of serotonin and TGFB1. Each sample then was stained for H&E, serotonin, and TGFB1, respectively ( Figure 8A-C) . Notably, serotonin levels in inflammation and cirrhosis samples were significantly higher in males than in females ( Figure 8D ). This sex disparity was less evident in HCC samples but still was very significant. Similarly, male-biased TGFB1 expression also was evident in inflammation, cirrhosis, and HCC samples ( Figure 8E ). Serotonin and TGFB1 protein showed a positive and significant correlation in both inflammation and cirrhosis patients, suggesting the molecular mechanism of serotonin-induced TGFB1 expression potentially translated in this cohort of patients. However, the correlation between the 2 molecules was abrogated in HCC patients, suggesting other confounding factors might contribute to TGFB1 expression in HCC patients ( Figure 8F-H) .
Discussion
Higher Expression of Serotonin in Males Contributed to Sex Disparity via Htr2b Activation of HSCs
In our investigation of human liver disease samples, serotonin levels were increased significantly in inflammation and cirrhosis, and marginally in HCC samples as compared with normal liver control samples. This is consistent with a previous observation that serotonin was a more sensitive serum marker for cirrhosis and HCC than afetoprotein. 32 The level of serotonin in HCC was significantly lower than in inflammation and cirrhosis samples, suggesting that the contribution of serotonin to liver diseases is possibly more important in early phases of the progression to HCC. Notably, in the cohort of human patients we analyzed, an apparent sex-dependent accumulation was observed in both inflammation and cirrhosis samples because serotonin was generally not detected in female patients of both stages. This is in line with the prevailing knowledge that men have a significantly higher rate of serotonin synthesis than women. 39 Our zebrafish studies recapitulated the sex disparity of serotonin accumulation, which likely can be attributed to the difference in the expression and phosphorylation of rate-limiting enzyme Tph1a. A previously conducted study suggested androgen to be responsible for the activation of Tph1 in macaques, thus providing a link to the sex difference in serotonin. 40 The sex differential production of serotonin and HSC density and activation also similarly were observed in other oncogeneinduced (xmrk and Myc) zebrafish HCC models generated in our laboratory 18, 19 ; thus, the involvement of serotonin and HSCs in the sex disparity of HCC is not oncogenespecific (our unpublished observations).
Serotonin can act on a variety of serotonin receptors. We showed that Htr2b was highly expressed in HSCs, consistent with a previously reported mouse study. 34 The sex disparity in serotonin synthesis resulted in a higher rate of Htr2b-mediated activation of HSCs in males than in females, and led to both a higher density of total HSCs and a higher percentage of activated HSCs, in line with a human HCC patient study in which male patients had a higher density of HSCs than female patients. 16 In this study, increased Htr2b activation in HSCs resulted in overexpression of Tgfb1. Both inactivation of HSCs and depletion of TgfB1 signaling significantly relaxed the rate of carcinogenesis in male kras V12 -expressing livers, consistent with the current notion that TGFB1 acts as a protumor cytokine in human HCC. 41 HSCs Maintain Sex Disparity in HCC via a Serotonin/Tgfb1 Loop In our zebrafish study, serotonin level was found to be dependent on Htr2b activation. A role of TGFB1 in the regulation of TPH1 expression and phosphorylation via ERK and SMAD pathways has been shown in human cells. 42, 43 Depletion of HSCs via Htr2b antagonist and inhibition of Tgfb signaling in kras V12 -expressing livers of male zebrafish inhibited P-Tph1 and serotonin expression, suggesting that the role of activated HSCs on serotonin synthesis is mediated by Tgfb signaling. Hence, the robust activation of HSCs via Htr2b in male kras V12 -expressing livers would establish a positive feedback loop, ensuring constant and high levels of serotonin synthesis, thus accelerating carcinogenesis via the multifunctional cytokine, Tgfb1. Although this molecular mechanism similarly would exist in female kras V12 -expressing livers, the lower initial P-Tph level would result in the initiation of a less-robust feedback loop. This is at least in part consistent with our analyses on human liver disease samples. TGFB1 showed a similar sex-biased expression in inflammation, cirrhosis, and HCC patients. However, significant correlation between serotonin and TGFB1 was observed only in inflammation and cirrhosis samples but not in HCC patients, possibly because of many other factors affecting TGFB1 expression during carcinogenesis.
In summary, as shown in Figure 9 , data from both zebrafish models and human liver disease samples showed the differential accumulation of serotonin during liver disease progression between sexes, which could be attributed to the disparity of P-Tph level in the 2 sexes of krasþ zebrafish. We further showed the novel role of serotonin in initiating and promoting a sex-disparate tumor microenvironment via Htr2b activation of HSCs. Htr2b-activated HSCs expressed Tgfb1, which not only promoted HCC progression but also increased serotonin synthesis. Hence, HSCs not only promote liver tumor progression but also play a vital role in maintaining the sex disparity observed in HCC patients.
